change in operating results Quarter 1 Ending March 31, 2018 with details as follows: Unit : million baht Revenue For the year ended March 31, 2017. 2018 2017 Add (Reduce) Amount Percentage Service revenue
: Operating Performance Results - Q3/2017 (vs Q3/2016) (Baht – Million) Q3/2017 Q3/2016 Changes YoY (Increase + / Decrease -) Amount % Amount % Amount % Hotels Business Revenues 2,093.9 43.1% 2,096.0 44.4% -2.1
17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2
clients to decrease by 30 percent compared to normal situation. The real estate business of the company continued to slow down, therefore, the company focuses on real estate rental for living and operating
Commercial Development business decrease by Baht 15 Million. Other revenue of Baht 274 Million representing an increase from the same quarter of the previous year by Baht 209 Million mainly from the change in
%, together with lower selling and administrative expenses. The cost of sales for the first half of the year 2020 was 14.35 million baht, a decrease of 16.51% from the same period of the previous year due to
performance of the Group Unit: Million Baht 2018 2017 Increase (decrease) Variance (%) Total revenues 8,080 7,165 915 13% Net profit 526 272 254 93% The Group has total revenues of Baht 8,080 million for 2018
. Finance costs did not significantly change from 2017 to 2018. 8. Share of profit of associates and joint ventures was THB 287 million, a decrease of THB 173 million or down by 37.6% over the same period
in the previous year. The Company would like to clarify the reasons for the change in profits for 2018 compared to the previous year, as follows: 1. Revenue In 2018, the Company had total revenues, as